AIIC
AJU IB Investment Company Portfolio holdings
AUM
$91.9M
This Quarter Return
+23.63%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$155M
AUM Growth
+$155M
(-11%)
Cap. Flow
-$18.3M
Cap. Flow
% of AUM
-11.8%
Top 10 Holdings %
Top 10 Hldgs %
99.95%
Holding
11
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Apellis Pharmaceuticals
APLS
|
$14.5M |
| 2 |
Atea Pharmaceuticals
AVIR
|
$3.79M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Atea Pharmaceuticals
AVIR
$267M
| $57.4M | 37.04% | 1,637,331 -108,000 | -6% | -$3.79M |
|
2
Kymera Therapeutics
KYMR
$2.95B
| $37.5M | 24.22% | 639,059 | – | – |
|
3
Seer Inc
SEER
$115M
| $28.2M | 18.19% | 816,375 | – | – |
|
|
4
Apellis Pharmaceuticals
APLS
$3.48B
| $20.6M | 13.29% | 624,962 -440,000 | -41% | -$14.5M |
|
5
Sutro Biopharma
STRO
$72.7M
| $3.31M | 2.13% | 175,000 | – | – |
|
6
RAPT Therapeutics
RAPT
$188M
| $3.09M | 1.99% | 99,503 | – | – |
|
7
Clearside Biomedical
CLSD
$28.9M
| $1.76M | 1.14% | 293,555 | – | – |
|
|
MTEM
8
DELISTED
Molecular Templates, Inc.
MTEM
| $1.37M | 0.89% | 204,809 | – | – |
|
9
Kezar Life Sciences
KZR
$28.9M
| $1.11M | 0.72% | 128,916 | – | – |
|
|
RNTX
10
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $528K | 0.34% | 517,558 | – | – |
|
|
BLCM
11
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $75K | 0.05% | 25,651 | – | – |
|